Global Health Stock Screener | Share Price & Fundamental Analysis
MEDANTA
Hospitals
Share Price NSE
₹1130.00
▼
-9.70 (-0.85%)
Share Price BSE
₹1130.25
▼
-8.75 (-0.77%)
Track Global Health share price live with TickJournal's free stock screener.
Analyze Global Health share price history trends and compare 52-week high low
levels.
Calculate MEDANTA stock fair value using fundamental analysis and view live share price charts.
Determine Global Health share intrinsic value and compare it with current MEDANTA share price.
Record your Global Health trades in TickJournal's free trading journal and track your portfolio performance.
Global Health Market Cap
₹30,617.91 Cr.
MEDANTA P/E Ratio (TTM)
59.98
EPS (TTM)
₹17.92
Dividend Yield
-
Debt to Equity
0.24
MEDANTA 52 Week High
₹1428.30
Global Health 52 Week Low
₹1030.00
Operating Margin
19.00%
Profit Margin
10.59%
MEDANTA Revenue (TTM)
₹954.00
EBITDA
₹198.00
Net Income
₹101.00
Total Assets
₹4,766.00
Total Equity
₹3,388.00
Global Health Share Price History - Stock Screener Chart
Screen MEDANTA historical share price movements with interactive charts. Analyze price trends and patterns.
Global Health Company Profile - Fundamental Screener
Screen Global Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MEDANTA shares.
Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over...more
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
Chairperson/CEO
Naresh Kumar Trehan
ISIN
INE474Q01031
Website
https://www.medanta.org
Global Health Balance Sheet Screener
Screen MEDANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 4,766 | 4,304 | 4,116 | 3,146 | 2,694 | 0 | 2,430 | 1,984 |
| Current Assets | 1,533 | 1,509 | 1,580 | 812 | 502 | 0 | 489 | 472 |
| Fixed Assets | 2,514 | 2,236 | 2,050 | 1,776 | 1,616 | 0 | 1,194 | 1,094 |
| Liabilities | ||||||||
| Total Liabilities | 4,766 | 4,304 | 4,116 | 3,146 | 2,694 | 0 | 2,430 | 1,984 |
| Current Liabilities | 760 | 781 | 1,115 | 1,110 | 907 | 0 | 839 | 432 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 3,388 | 2,906 | 2,428 | 1,616 | 1,382 | 0 | 1,296 | 1,217 |
| Share Capital | 54 | 54 | 54 | 51 | 50 | 0 | 49 | 81 |
| Reserves & Surplus | 3,333 | 2,852 | 2,375 | 1,565 | 1,300 | 0 | 1,214 | 1,136 |
Global Health Income Statement Screener - Profit & Revenue Analysis
Screen Global Health income statement and profit fundamentals.
Analyze MEDANTA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Global Health share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 954 | 1,051 | 1,135 | 1,143 | 836 | 883 | 975 | 960 | 732 | 795 | 865 | 855 | 533 | 627 | 695 |
| Expenses | 757 | 784 | 868 | 940 | 629 | 675 | 728 | 706 | 540 | 595 | 631 | 621 | 441 | 485 | 523 |
| EBITDA | 198 | 267 | 267 | 203 | 207 | 208 | 247 | 254 | 192 | 199 | 234 | 234 | 92 | 142 | 172 |
| Operating Profit % | 19.00% | 24.00% | 21.00% | 16.00% | 22.00% | 22.00% | 24.00% | 25.00% | 24.00% | 24.00% | 25.00% | 26.00% | 15.00% | 21.00% | 23.00% |
| Depreciation | 49 | 45 | 50 | 61 | 46 | 47 | 49 | 49 | 38 | 40 | 43 | 44 | 35 | 36 | 37 |
| Interest | 15 | 14 | 17 | 22 | 18 | 18 | 16 | 16 | 21 | 18 | 20 | 18 | 28 | 19 | 18 |
| Profit Before Tax | 133 | 208 | 200 | 120 | 143 | 144 | 181 | 189 | 133 | 141 | 171 | 172 | 29 | 87 | 117 |
| Tax | 32 | 49 | 41 | 25 | 16 | 37 | 50 | 46 | 32 | 39 | 45 | 49 | 12 | 28 | 31 |
| Net Profit | 101 | 159 | 158 | 95 | 127 | 106 | 131 | 143 | 101 | 102 | 125 | 124 | 18 | 59 | 86 |
| EPS | 3.77 | 5.92 | 5.89 | 3.54 | 4.74 | 3.96 | 4.87 | 5.32 | 3.77 | 3.80 | 4.66 | 4.61 | 0.69 | 2.32 | 3.38 |
Global Health Cash Flow Screener - Liquidity Fundamentals
Screen MEDANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 624 | 612 | 645 | 311 | 242 | 175 | 166 | 63 | 228 | 213 |
| Investing Activities | -721 | -441 | -342 | -421 | -239 | -87 | -249 | -69 | -241 | -126 |
| Financing Activities | -97 | -514 | 346 | 160 | -81 | -1 | 97 | 9 | -7 | -88 |
| Net Cash Flow | -194 | -343 | 648 | 50 | -78 | 87 | 14 | 3 | -20 | 0 |
Global Health Shareholding Pattern Screener
See Global Health shareholding pattern with promoter, FII, and DII holdings.
Check Global Health promoter holding and ownership changes for MEDANTA on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 33.03% | 33.01% | 33.01% | 33.01% | 33.04% | 33.04% | 33.04% | 33.03% |
| FII Holding | 11.76% | 11.54% | 11.40% | 10.53% | 12.09% | 12.94% | 12.20% | 12.47% |
| DII Holding | 11.93% | 12.20% | 12.98% | 14.00% | 10.25% | 10.57% | 11.11% | 10.51% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.53% | 6.48% | 6.03% | 5.95% | 7.14% | 6.28% | 6.54% | 6.74% |
| Other Holding | 36.75% | 36.77% | 36.58% | 36.51% | 37.47% | 37.16% | 37.10% | 37.24% |
| Shareholder Count | 154,688 | 156,372 | 155,806 | 151,241 | 166,253 | 155,307 | 149,722 | 148,633 |
Global Health Share Dividend Screener - Share Yield Analysis
Check Global Health dividend history with payout and yield data.
View Global Health dividend details including ex-dates and amounts for MEDANTA stock.
Global Health Stock Index Membership
See which indices include Global Health stock.
Check MEDANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Global Health Market Events Screener - Corporate Actions
Get Global Health corporate actions including splits, bonuses, and buybacks.
Check Global Health stock events that may affect MEDANTA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -6.51% | ||
| Annual General Meeting | NA | 2.14% | ||
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | 8.16% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -5.04% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 0.50 /share | 11.88% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -1.20% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 3.17% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 4.13% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -3.80% |
| 2024-08-03 | 2024-08-03 | Extraordinary General Meeting | NA | -7.46% |
Global Health Competitors Screener - Peer Comparison
Screen MEDANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 108,450 | 58.09 | 21,994 | 14.76% | 1,505 | 71.67 |
| Max Healthcare Institute | 102,491 | 72.90 | 7,184 | 28.65% | 1,076 | 57.45 |
| Fortis Healthcare | 69,211 | 67.51 | 7,850 | 13.25% | 809 | 61.23 |
| Narayana Hrudayalaya | 37,190 | 45.05 | 5,575 | 12.29% | 790 | 51.14 |
| Aster DM Healthcare | 31,082 | 87.06 | 4,287 | 15.12% | 337 | 57.70 |
| Global Health | 30,618 | 59.98 | 3,771 | 12.59% | 481 | 51.74 |
| Krishna Institute of Medical Sciences | 27,498 | 88.80 | 3,067 | 21.98% | 415 | 65.63 |
| Dr. Agarwal's Health Care | 14,401 | 90.43 | 1,757 | 27.64% | 110 | 44.14 |
| Rainbow Childrens Medicare | 12,046 | 47.51 | 1,567 | 17.46% | 244 | 45.81 |
| Healthcare Global Enterprises | 8,211 | 328.90 | 2,258 | 17.03% | 49 | 40.68 |
Global Health Company Announcements - News Screener
Screen MEDANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-17 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-02-11 | Financial Results For Third Quarter And Nine Months Ended December 31 2025. | View |
| 2026-02-11 | Board Meeting Outcome for Intimation Under Regulation 30 Of Listing Regulations. | View |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-24 | Board Meeting Intimation for Board Meeting Intimation For Schedule Of Board Meeting For Third Quarter And Nine-Months Ended December 31 2025 Under Regulation 29 Of Listing Regulations. | View |
| 2026-01-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-07 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating Assigned By SES ESG Research Private Limited. | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |